logo

For the Inventor, By the Inventor

Seoul, South Korea

Rnl Bio Co., Ltd.

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 55.6


Forward Citations = 46

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Jeong Chan Ra (8 out of 17 patents)

silverMedal Sung Keun Kang (3 out of 10 patents)

bronzeMedal Byeung Gie Kim (2 out of 2 patents)

4.  Hyuk Joon Kwon (2 out of 9 patents)

5.  Hyoeun Kim (1 out of 23 patents)

6.  Hang Young Lee (1 out of 2 patents)

7.  Seob Shin (1 out of 6 patents)

8.  Huu Tung Nguyen (1 out of 1 patent)

9.  Myeong-Jin Nam (1 out of 1 patent)

10.  Young Ho Kim (1 out of 34 patents)

11.  Kyung Sun Kang (1 out of 13 patents)

12.  Yun Jung Kim (1 out of 6 patents)

13.  Jung Youn Jo (1 out of 2 patents)

14.  Ju Yeon Seo (1 out of 1 patent)

15.  Sun Jin Baek (1 out of 1 patent)


9 patents:

1. 9211306 - Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose (2015-12-15),
2. 8911802 - [object Object] (2014-12-16),
3. 8871513 - Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same (2014-10-28),
4. 8808682 - Method for inducing migration of adipose-derived adult stem cells (2014-08-19),
5. 8470378 - [object Object] (2013-06-25),
6. 8455251 - Method for isolating and culturing adult stem cells derived from human amniotic epithelium (2013-06-04),
7. 8426370 - Diaryl hepatonoid-based compounds and use thereof (2013-04-23),
8. 7807461 - Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same (2010-10-05),
9. 7687062 - Method for diagnosing colon cancer (2010-03-30),
Company Overview
Rnl Bio Co., Ltd. is a leading biotechnology company specializing in stem cell research and regenerative medicine. Founded in 2000, the company is focused on developing and commercializing innovative cell therapy solutions for various diseases and conditions. With state-of-the-art facilities and a team of experienced researchers, Rnl Bio is dedicated to advancing the field of regenerative medicine to improve patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Rnl Bio Co., Ltd. USPTO Patent Assignee Logo
9 Patents

#436 in Seoul

#1,189 in South Korea

Seoul, KR
Seoul, South Korea

Rnl Bio Co., Ltd.

Forward Citations = 46

18 inventors:

goldMedal Jeong Chan Ra (8 out of 17 patents)

silverMedal Sung Keun Kang (3 out of 10 patents)

bronzeMedal Byeung Gie Kim (2 out of 2 patents)

4.  Hyuk Joon Kwon (2 out of 9 patents)

5.  Hyoeun Kim (1 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rnl Bio Co., Ltd.. Retrieved from https://idiyas.com/company/rnl-bio-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…